1. Preparation of (13)C-labeled ceramide by acetic acid bacteria and its incorporation in mice.
- Author
-
Fukami H, Tachimoto H, Kishi M, Kaga T, Waki H, Iwamoto M, and Tanaka Y
- Subjects
- Administration, Oral, Animals, Carbon Isotopes, Ceramides administration & dosage, Ceramides metabolism, Gas Chromatography-Mass Spectrometry, Isotope Labeling, Male, Mice, Mice, Inbred C57BL, Acetic Acid metabolism, Acetobacter metabolism, Ceramides biosynthesis
- Abstract
We prepared 2-hydroxypalmitoyl-sphinganine (dihydroceramide) labeled with a stable isotope by culturing acetic acid bacteria with (13)C-labeled acetic acid. The GC/MS spectrum of the trimethylsilyl derivative of (13)C-labeled dihydroceramide gave molecular ions with an increased mass of 12-17 Da over that of nonlabeled dihydroceramide. The fragment ions derived from both sphinganine base and 2-hydroxypalmitate were confirmed to be labeled with the stable isotope in the spectrum. Therefore, (13)C-labeled dihydroceramide can be an extremely useful tool for analyzing sphingolipid metabolism. The purified [(13)C]dihydroceramide was administered orally to mice for 12 days, and the total sphingoid base fractions in various tissues were analyzed by GC/MS. The spectrum patterns specific to (13)C-labeled sphingoids were detected in the tissues tested. Sphinganine pools in skin epidermis, liver, skeletal muscle, and synapse membrane in brain were replaced by [(13)C]sphinganine at about 4.5, 4.0, 1.0, and 0.3%, respectively. Moreover, about 1.0% of the sphingosine pool in the liver was replaced by [(13)C]sphingosine, implying that exogenous dihydroceramide can be converted to sphingosine. These results clearly indicate that ingested dihydroceramide can be incorporated into various tissues, including brain, and metabolized to other sphingolipids.
- Published
- 2010
- Full Text
- View/download PDF